Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication (original) (raw)
Balczon R, Bao L, Zimmer WE, Brown K, Zinkowski RP, Brinkley BR . (1995). Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells. J Cell Biol130: 105–115. ArticleCAS Google Scholar
Bennett RA, Izumi H, Fukasawa K . (2004). Induction of centrosome amplification and chromosome instability in p53-null cells by transient exposure to subtoxic levels of S-phase-targeting anticancer drugs. Oncogene23: 6823–6829. ArticleCAS Google Scholar
Blair Zajdel ME, Blair GE . (1988). The intracellular distribution of the transformation-associated protein p53 in adenovirus-transformed rodent cells. Oncogene2: 579–584. CASPubMed Google Scholar
Brown CR, Doxsey SJ, White E, Welch WJ . (1994). Both viral (adenovirus E1B) and cellular (hsp70, p53) components interact with centrosomes. J Cell Physiol160: 47–60. ArticleCAS Google Scholar
Campomenosi P, Monti P, Aprile A, Abbondandolo A, Frebourg T, Gold B et al. (2001). p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Oncogene20: 3573–3579. ArticleCAS Google Scholar
Ciciarello M, Mangiacasale R, Casenghi M, Zaira Limongi M, D'Angelo M, Soddu S et al. (2001). p53 displacement from centrosomes and p53-mediated G1 arrest following transient inhibition of the mitotic spindle. J Biol Chem276: 19205–19213. ArticleCAS Google Scholar
D'Assoro AB, Lingle WL, Salisbury JL . (2002). Centrosome amplification and the development of cancer. Oncogene40: 6146–6153. Article Google Scholar
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). WAF-1, a potential mediator of p53 tumor suppression. Cell75: 817–825. ArticleCAS Google Scholar
Fukasawa K . (2005). Centrosome amplification, chromosome instability, and cancer development. Cancer Lett230: 6–19. ArticleCAS Google Scholar
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell75: 805–816. ArticleCAS Google Scholar
Hinchcliffe EH, Sluder G . (2002). Two for two: Cdk2 and its role in centrosome doubling. Oncogene21: 6154–6160. ArticleCAS Google Scholar
Joshi HC . (1994). Microtubule organizing centers and _γ_-tubulin. Curr Opin Cell Biol6: 54–62. ArticleCAS Google Scholar
Kaul SC, Reddel RR, Mitsui Y, Wadhwa R . (2001). An N-terminal region of Mot-2 binds to p53 in vitro. Neoplasia3: 110–114. ArticleCAS Google Scholar
Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T et al. (2004). Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res64: 4800–4809. ArticleCAS Google Scholar
Ma Z, Izumi H, Kanai M, Kabuyama Y, Ahn NG, Fukasawa K . (2006). Mortalin controls centrosome duplication via modulating centrosomal localization of p53. Oncogene25: 5377–5390. ArticleCAS Google Scholar
Matsumoto Y, Hayashi K, Nishida E . (1999). Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol9: 429–432. ArticleCAS Google Scholar
Mazia D . (1987). The chromosome cycle and the centrosome cycle in the mitotic cycle. Int Rev Cytology100: 49–92. ArticleCAS Google Scholar
Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE . (2002). p53 and p21 form an inducible barrier that protects cells against cyclin E–cdk2 deregulation. Curr Biol12: 1817–1827. ArticleCAS Google Scholar
Morris VB, Brammall J, Noble J, Reddel R . (2000). p53 localizes to the centrosomes and spindles of mitotic cells in the embryonic chick epiblast, human cell lines, and human primary culture: an immunofluorescence study. Exp Cell Res256: 122–130. ArticleCAS Google Scholar
Mussman JG, Horn HF, Carroll PE, Okuda M, Tarapore P, Donehower LA et al. (2000). Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene19: 1635–1646. ArticleCAS Google Scholar
Oikawa T, Okuda M, Ma Z, Goorha R, Tsujimoto H, Inokuma H et al. (2005). Transcriptional control of BubR1 by p53 and suppression of centrosome amplification by BubR1. Mol Cell Biol25: 4046–4061. ArticleCAS Google Scholar
Shinmura K, Tarapore P, Tokuyama Y, George KR, Fukasawa K . (2005). Characterization of centrosomal association of nucleophosmin/B24 linked to Crm1 activity. FEBS Lett579: 6621–6634. ArticleCAS Google Scholar
Smith PD, Crossland S, Parker G, Osin P, Brooks L, Waller J et al. (1999). Novel p53 mutants selected in BRCA-associated tumors which dissociate transformation suppression from other wild-type p53 functions. Oncogene18: 2451–2459. ArticleCAS Google Scholar
Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, Wahl GM . (1999). A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J18: 1660–1672. ArticleCAS Google Scholar
Tang HY, Zhao K, Pizzolato JF, Fonarev M, Langer JC, Manfredi JJ . (1998). Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53. J Biol Chem273: 29156–29163. ArticleCAS Google Scholar
Tarapore P, Fukasawa K . (2002). Loss of p53 and centrosome hyperamplification. Oncogene21: 6234–6240. ArticleCAS Google Scholar
Tarapore P, Horn HF, Tokuyama Y, Fukasawa K . (2001a). Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway. Oncogene20: 3173–3184. ArticleCAS Google Scholar
Tarapore P, Tokuyama Y, Horn HF, Fukasawa K . (2001b). Difference in the centrosome duplication regulatory activity among p53 ‘hot spot’ mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53. Oncogene20: 6851–6863. ArticleCAS Google Scholar
Wadhwa R, Takano S, Robert M, Yoshida A, Nomura H, Reddel RR et al. (1998). Inactivation of tumor suppressor p53 by Mot-2, a hsp70 family member. J Biol Chem273: 29586–29591. ArticleCAS Google Scholar
Woods DB, Vousden KH . (2001). Regulation of p53 function. Exp Cell Res264: 56–66. ArticleCAS Google Scholar
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D . (1993). p21 is a universal inhibitor of cyclin kinases. Nature366: 701–704. ArticleCAS Google Scholar
Zhang Y, Xiong Y . (2001). A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science292: 1910–1915. ArticleCAS Google Scholar